Evidence map›Paper›PMID 41578938›Full record

ArticleThe FEBS journal2026

Regulation of PHOX2B gene expression by the long non-coding natural antisense RNA PHOX2B-AS1.

Simona Di Lascio, Ana Lucia Cuadros Gamboa, Martina Bertocchi, Filippo Chiesa, Francesca Cargnin, Ettore Mosca, Paride Pelucchi, Viviana Tritto, Stefania Corti, Isabella Ceccherini and 3 more

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. CRISPR/Cas9-mediatedFrontiers in physiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Simona Di LascioDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0002-5971-1515
Ana Lucia Cuadros GamboaDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Martina BertocchiDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Filippo ChiesaDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Francesca CargninDepartment of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.
Ettore MoscaInstitute of Biomedical Technologies, National Research Council, Segrate (Milan), Italy.
Paride PelucchiInstitute of Biomedical Technologies, National Research Council, Segrate (Milan), Italy.
Viviana TrittoDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Stefania CortiDepartment of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.
Isabella CeccheriniUOSD Aggregation Area of Research Laboratories, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Paola RivaDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Roberta BenfanteDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.
Diego FornasariDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy.ORCID https://orcid.org/0000-0002-9668-3103

Funding

Associazione Italiana per la Sindrome da Ipoventilazione Centrale Congenita (A.I.S.I.C.C.)CCHS NetworkFondazione Antonio Carlo MonzinoFondazione Telethon GMR22T1041Italian Ministry of University and ResearchRegione Lombardia
6 · The paper itself

Abstract

Paired mesoderm homeobox protein 2B (PHOX2B) is a transcription factor essential for autonomic nervous system development. Heterozygous mutations in the PHOX2B gene are associated with neurodevelopmental disorders, including congenital central hypoventilation syndrome and Hirschsprung's disease. Additionally, PHOX2B plays a role in the genetic landscape of neuroblastoma, with mutations detected in both familial and sporadic forms of this rare cancer. Notably, PHOX2B is highly expressed in most neuroblastoma cells. Despite its significance, little is known about the regulation of PHOX2B gene expression, and limited attention has been given to the genomic features of the antisense strand at the PHOX2B locus, although the presence of an antisense transcript is suggested by bioinformatics analyses. In this study, we characterize the recently annotated human antisense transcript PHOX2B-AS1 and the previously unidentified mouse antisense Phox2b transcript. Our findings reveal that PHOX2B positively regulates PHOX2B-AS1 expression and that inhibiting the antisense transcript reduces PHOX2B protein levels. Together, these results provide strong evidence for the existence of a gene antisense to PHOX2B and highlight a strict correlation and reciprocal regulation between PHOX2B and PHOX2B-AS1.

Indexed as

Gene Expression RegulationHomeodomain ProteinsRNA, AntisenseRNA, Long NoncodingTranscription FactorsAnimalsBase SequenceCell Line, TumorHumansMiceNeuroblastomaHomeodomain ProteinsNBPhox proteinPhox2b protein, mouseRNA, AntisenseRNA, Long NoncodingTranscription Factorscongenital central hypoventilation syndromelncRNAnatural antisense transcriptneuroblastomaPHOX2B

Identifiers

PMID41578938
PMCPMC13278362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.